Malaysia’s aspiration to achieve zero dengue deaths by 2030 demands renewed confidence in safe, effective vaccination as part of a dengue integrated management strategy.
Experts say vaccination, as part of integrated dengue prevention and management measures, is crucial for sustained dengue control. Immunity goes down when transmission is reduced from mosquito control, raising risk of severe disease.
With vigilant monitoring and coordinated action, Malaysia stands on the threshold of a new era in dengue prevention — one guided by science, strategy, and sustained hope.
Health Minister Dzulkefly Ahmad said the Qdenga vaccine won’t be added to the NIP yet, as Malaysia hasn’t met WHO’s 60% seroprevalence threshold in children. The government will instead expand Wolbachia mosquito use, which has shown 45–100% effectiveness.
Doctors are urged to stay alert as dengue mimics other illnesses and often shows no symptoms, complicating diagnosis. Experts say dengue is now hyper-endemic in Malaysia. Vaccination, though not in the NIP, offers strong protection against severe cases.
Dr Zulkifli Ismail moots piloting free dengue vaccination in hotspots. Taman Medan rep Dr Afif Bahardin backs a targeted approach. Subang Jaya rep Michelle Ng and Bukit Gasing rep R. Rajiv say any dengue vax programme should get federal-state subsidies.
Pasir Gudang MP Hassan Abdul Karim says he supports subsidies for dengue vaccination; the Johor state government is considering providing subsidies for the shots. Total dengue cases in Johor rose 33% this year. "The problem of dengue is very serious."
Amid the escalating threat of dengue in Malaysia, the partners aim to engage up to 1.7 million policy and certificate holders, providing them with essential knowledge and resources to prevent the disease.
Malaysians say dengue vaccination is worth the value, describing it as an "investment" to protect themselves and their children, and to prevent loss of work productivity. Four-day hospitalisation for dengue can cost more than RM7,500.